Now Available On-demand

Insights-driven healthcare and life sciences systems are leveraging external datasets to drive key innovations in biomedical development processes. From accelerating the antiquated 17-year evidence-to-practice cycle to correcting the 80 percent clinical trial enrollment gap, companies have discovered that third-party data can support unparalleled scientific achievement. With the ability to make faster decisions with greater accuracy, the healthcare and life sciences sector can expedite the creation of new therapies and design more effective clinical trials – improving patient welfare and experience.

Join this webinar to learn about the critical role third-party datasets are playing in the evolution of the healthcare and life sciences industry. In this virtual session, you'll hear from QIAGEN and IBM Watson Health thought leaders as they uncover prescriptive guidance on how healthcare and life sciences datasets can accelerate the bench-to-bedside cycle through enhanced visualizations, machine learning algorithms, and curated genomics data.

Attendees will learn:

  • How to query and visualize data from across a range of published sources and consortia that have been reprocessed to a common standard by QIAGEN’s curators
  • How to incorporate QIAGEN’s harmonized molecular and genomics data to identify trends from otherwise scattered information and gain deeper insights
  • How to support protocol development and real-world evidence generation with IBM Watson Health data
  • How to find, subscribe to, and copy third-party data on AWS Data Exchange

Who Should Attend?

Data and analytics leaders, Chief Data Officers, Chief Research Information Officers, SVP / VP of Clinical Quality, Chief Medical Information Officers, procurement leaders, data scientists, business intelligence, and analytics professionals


Fred Lee, MD, MPH, Healthcare & Life Sciences Leader, AWS Data Exchange

Dr. Lee provides physician leadership for AWS Data Exchange where he is focused on transforming and disrupting the exchange of healthcare and life sciences data towards a cloud-native, socially responsible, economically sustainable, and privacy-preserving state. Fred brings a broad range of professional experience to this role, having served as a practicing academic physician, a health system executive, founder of a precision medicine startup, an industry market strategy executive, and as an industry leader for precision medicine and real-world evidence in the healthcare and life sciences sectors. Fred is a member of the American Medical Informatics Association and is an Industry Advisory Board appointee for the Cancer Informatics Society. He received his MD from Stony Brook School of Medicine, his MPH from the Columbia Mailman School of Public Health and is a licensed physician in the state of New York, with a clinical background in general surgery and preventive medicine.

Matt Newman, PhD, Vice President of Business Development & Professional Services, QIAGEN

Matt Newman is the Vice President of Business Development & Professional Services at QIAGEN Digital Insight, specializing in partnerships for bioinformatics software and data solutions, as well as helping to lead the QIAGEN Digital Insights Professional Services organization. Before joining QIAGEN, Matt helped to form OmicSoft Corporation, specializing in software and data services for the analysis of genomic datasets. OmicSoft Corporation was acquired In January 2017. Prior to OmicSoft, Matt worked in the lab at Glaxo Smith Kline, utilizing skills learned with a BS from Penn State University.

Luke Boulanger, MA, MBA, Lead Offering Manager for MarketScan Databases, IBM Watson Health

Luke Boulanger is an academically-trained health economist, specializing in health economics and outcomes research for approximately 25 years and focuses on the design, implementation, and dissemination of real-world observational studies. Leveraging his extensive experience in several therapeutic areas, Luke directs hybrid and retrospective studies, analyzing and synthesizing clinical and economic data from a wide variety of sources. Luke has authored over 45 peer-reviewed publications in journals like Diabetes Care, COPD, HIV Medicine, Annals of Pharmacotherapy, and Neurology and is currently a PhD candidate in economics.

Colin Marden, Solutions Architect, AWS

Colin Marden is a Solutions Architect in the financial services industry supporting AWS Enterprise Greenfield customers in their journey to modernize, transform, and migrate on-premises workloads to the AWS Cloud. Colin is a champion and specialist for Amazon QuickSight and AWS Data Exchange, regularly speaking at AWS and partner events on subjects like data engineering and visualization.

Register for the webinar

About AWS Marketplace:

AWS Marketplace is a digital software catalog that makes it easy to find, try, buy, deploy, and manage software that runs on AWS. AWS Marketplace has a broad and deep selection of security solutions offered by hundreds of independent software vendors, spanning infrastructure security, logging and monitoring, identity and access control, data protection, and more. These products can be integrated with AWS Services and other existing technologies, enabling you to deploy a comprehensive security architecture across your AWS and on-premises environments. Visit to learn more.

*The views and opinions of QIAGEN and IBM Watson Health and their presenters are their own and do not necessarily reflect the positions of AWS